Variant report
Variant | esv2762255 |
---|---|
Chromosome Location | chr2:52381972-52400156 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574241673 | chr2:52385216-52385217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543338603 | chr2:52385256-52385257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191239280 | chr2:52385295-52385296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575216459 | chr2:52385326-52385327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs180754662 | chr2:52385347-52385348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185080339 | chr2:52385356-52385357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551360131 | chr2:52385368-52385369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190734074 | chr2:52385376-52385377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546388035 | chr2:52385388-52385389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559957949 | chr2:52385389-52385390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567455370 | chr2:52385394-52385395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368871532 | chr2:52385404-52385405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549290558 | chr2:52385414-52385415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114950098 | chr2:52385425-52385426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115940773 | chr2:52385458-52385459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538065805 | chr2:52385461-52385462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559603040 | chr2:52385467-52385468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550022599 | chr2:52385477-52385478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7349359 | chr2:52385489-52385490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369826612 | chr2:52385541-52385542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571763729 | chr2:52385577-52385578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183202653 | chr2:52385580-52385581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554389681 | chr2:52385584-52385585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369870216 | chr2:52385585-52385586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574204720 | chr2:52385641-52385642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536515959 | chr2:52385657-52385658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556832126 | chr2:52385658-52385659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571421691 | chr2:52385696-52385697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115640387 | chr2:52385697-52385698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149768274 | chr2:52385714-52385715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374277908 | chr2:52385745-52385746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12476761 | chr2:52385756-52385757 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs370449771 | chr2:52385778-52385779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145777413 | chr2:52385840-52385841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77260916 | chr2:52385883-52385884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560071207 | chr2:52385951-52385952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529109933 | chr2:52385962-52385963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35886094 | chr2:52385964-52385965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372607772 | chr2:52386006-52386007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11675869 | chr2:52386032-52386033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542513512 | chr2:52386037-52386038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1922201 | chr2:52386043-52386044 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs187937400 | chr2:52386077-52386078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1922202 | chr2:52386104-52386105 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs148954946 | chr2:52386110-52386111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12477631 | chr2:52386144-52386145 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs191741897 | chr2:52386158-52386159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117203182 | chr2:52386166-52386167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs375924649 | chr2:52386175-52386176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368539778 | chr2:52386180-52386181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Schizophrenia | 23813976 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52385200-52385800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr2:52385800-52389800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:52389200-52389600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:52389200-52389600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr2:52389800-52390000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |